Geller Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $236K | Sell |
586
-1,434
| -71% | -$577K | 0.02% | 232 |
|
|
2024
Q3 | $939K | Sell |
2,020
-754
| -27% | -$351K | 0.07% | 79 |
|
|
2024
Q2 | $1.3M | Sell |
2,774
-38
| -1% | -$17.8K | 0.1% | 58 |
|
|
2024
Q1 | $1.18M | Sell |
2,812
-17
| -0.6% | -$7.11K | 0.1% | 64 |
|
|
2023
Q4 | $1.15M | Buy |
2,829
+109
| +4% | +$44.4K | 0.11% | 56 |
|
|
2023
Q3 | $946K | Sell |
2,720
-105
| -4% | -$36.5K | 0.11% | 62 |
|
|
2023
Q2 | $994K | Buy |
2,825
+921
| +48% | +$324K | 0.12% | 54 |
|
|
2023
Q1 | $600K | Sell |
1,904
-13
| -0.7% | -$4.1K | 0.09% | 53 |
|
|
2022
Q4 | $554K | Buy |
1,917
+75
| +4% | +$21.7K | 0.09% | 49 |
|
|
2022
Q3 | $533K | Sell |
1,842
-56
| -3% | -$16.2K | 0.12% | 43 |
|
|
2022
Q2 | $535K | Buy |
+1,898
| New | +$535K | 0.11% | 48 |
|